FOXO1 and metabolic dysfunction-associated steatotic liver disease: showed that in nonalcoholic fatty liver disease, the inhibition of FoxO1 in macrophages by miR-192 resulted in the release of a large number of proinflammatory cytokines, leading to M1 polarization and aggravating the progression of liver inflammation (31).